5-(3-((1S)-2,3-DIHYDRO-1-(2-OXO-3-OXAZOLIDINYL)-1H-INDEN-4-YL)-1,2,4-OXADIAZOL-5-YL)-2-(1-METHYLETHOXY)BENZONITRILE
UNII WB86YBX7HF
Substance Identification & Data
This profile provides standardized clinical and technical data for 5-(3-((1s)-2,3-dihydro-1-(2-oxo-3-oxazolidinyl)-1h-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-(1-methylethoxy)benzonitrile, uniquely identified by the FDA Unique Ingredient Identifier (UNII) WB86YBX7HF.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1306762-32-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C24H22N4O4 HBYQXRMJUJILDD-FQEVSTJZSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 5-(3-((1s)-2,3-dihydro-1-(2-oxo-3-oxazolidinyl)-1h-inden-4-yl)-1,2,4-oxadiazol-5-yl)-2-(1-methylethoxy)benzonitrile. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.